DNA methylation analysis
DNA methylation analysis is a genetic therapy with 47 clinical trials. Currently 2 active trials ongoing. Historical success rate of 97.3%.
Success Metrics
Based on 36 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
5
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
94.7%
36 of 38 finished
5.3%
2 ended early
2
trials recruiting
47
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Emotional Regulation in Children With ND: the Role of Genomic Variation, Proteomic Patterns, and Early Experience
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
Clinical Trials (47)
Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Emotional Regulation in Children With ND: the Role of Genomic Variation, Proteomic Patterns, and Early Experience
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
Decitabine, Vaccine Therapy, and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Bevacizumab and Lomustine for Recurrent GBM
Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma
Temozolomide in Treating Patients With Invasive Pituitary Tumors
DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200
Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
Drug Details
- Intervention Type
- GENETIC
- Total Trials
- 47